Quality Forum Lecture Series

Getting into the Weeds:  Evidence for Medical Marijuana Use

Please register by July 30th

Now that Cannabis use has been approved for medical use in many states, this month's PQA Quality Forum Lecture will focus on the clinical evidence available to support the use of MMJ (medical marijuana), the adverse effects that might result from its use and the latest state regulations governing its use.  Dr. Laura Borgelt from the University of Colorado A.F. Williams Family Medicine Center, will address the following objectives:

• Review recent regulations to determine status of marijuana across the United States.
• Describe the clinical pharmacology of marijuana and its active components
• Review various dosage formulations of marijuana available to patients.
• Evaluate and discuss clinical studies performed in patients with various conditions to determine the effectiveness of medical marijuana (MMJ).
• Identify adverse effects, psychiatric implications, potential drug interactions, and other patient safety issues that may occur with the use of MMJ.

Speaker:

Dr. Laura Borgelt serves as a clinical pharmacy specialist at the University of Colorado A.F. Williams Family Medicine Center which serves as the clinical teaching site for the Family Medicine Residency Program at the University of Colorado Hospital.  Dr. Borgelt is actively involved in several committees at the School of Pharmacy and within the University.  She is current member of the Curriculum Committee at the School of Pharmacy, and Chair of Faculty Council at the University of Colorado. She has also served on various committees in Colorado to ensure patient and medication safety including the prescription drug abuse prevention task force, pregnancy-related depression, and five different working groups with the State Licensing Authority and Department of Revenue to determine recommendations for rulemaking regarding medical and retail marijuana.